Literature DB >> 3167863

Characterization and properties of nine human ovarian adenocarcinoma cell lines.

S P Langdon1, S S Lawrie, F G Hay, M M Hawkes, A McDonald, I P Hayward, D J Schol, J Hilgers, R C Leonard, J F Smyth.   

Abstract

Four series of cell lines have been derived from patients with ovarian adenocarcinoma. Nine cell lines have been established at one from a solid metastasis. Six lines were derived from the ascites or pleural effusion of patients with poorly differentiated adenocarcinoma: PEO1, PEO4, and PEO6 from one patient, PEA1 and PEA2 from a second, and PEO16 from a third. Three lines (PEO14 and PEO23 from ascites and TO14 from a solid metastasis) were derived from a patient with a well-differentiated serous adenocarcinoma. Each set of cell lines was morphologically distinct. The five cell lines PEO1, PEO4, PEO6, PEA1, and PEA2 had cloning efficiencies on plastic of 1-2% and only a few cells in these lines expressed alkaline phosphatase or vimentin. Only a low percentage of these cells reacted with the monoclonal antibodies 123C3 and 123A8 but most reacted with OC125. Conversely the cell lines PEO14, TO14, PEO23, and PEO16 were characterized by low cloning efficiency values (less than 0.05%), marked expression of alkaline phosphatase and vimentin, and good reaction with 123C3 and 123A8 but not OC125. These four cell lines also exhibited dome formation. Four of the cell lines, PEO1, PEO4, PEO6, and PEO16, have been xenografted into immune-deprived mice and found to be tumorigenic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167863

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  115 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

3.  Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro.

Authors:  Anand G Patel; Silvana B De Lorenzo; Karen S Flatten; Guy G Poirier; Scott H Kaufmann
Journal:  Clin Cancer Res       Date:  2012-01-30       Impact factor: 12.531

4.  Automatic quantitation of cell colonies on petri dishes by computerized image analysis.

Authors:  A Bollea; M Masseroli; A Nicotra; P Beccaglia; S Sen; E Erba; G Balconi
Journal:  Cytotechnology       Date:  1995-10       Impact factor: 2.058

5.  E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.

Authors:  Craig MacKay; Eilís Carroll; Adel F M Ibrahim; Amit Garg; Gareth J Inman; Ronald T Hay; Arno F Alpi
Journal:  Cancer Res       Date:  2014-03-31       Impact factor: 12.701

6.  Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.

Authors:  Angelique W Whitehurst; Yang Xie; Scott C Purinton; Kathryn M Cappell; Jackie T Swanik; Brittany Larson; Luc Girard; John O Schorge; Michael A White
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

7.  Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.

Authors:  Courtney L Andersen; Matthew J Sikora; Michelle M Boisen; Tianzhou Ma; Alec Christie; George Tseng; Yongseok Park; Soumya Luthra; Uma Chandran; Paul Haluska; Gina M Mantia-Smaldone; Kunle Odunsi; Karen McLean; Adrian V Lee; Esther Elishaev; Robert P Edwards; Steffi Oesterreich
Journal:  Clin Cancer Res       Date:  2017-01-10       Impact factor: 12.531

8.  ATP11B mediates platinum resistance in ovarian cancer.

Authors:  Myrthala Moreno-Smith; J B Halder; Paul S Meltzer; Tamas A Gonda; Lingegowda S Mangala; Rajesha Rupaimoole; Chunhua Lu; Archana S Nagaraja; Kshipra M Gharpure; Yu Kang; Cristian Rodriguez-Aguayo; Pablo E Vivas-Mejia; Behrouz Zand; Rosemarie Schmandt; Hua Wang; Robert R Langley; Nicholas B Jennings; Cristina Ivan; Jeremy E Coffin; Guillermo N Armaiz; Justin Bottsford-Miller; Sang Bae Kim; Margaret S Halleck; Mary J C Hendrix; William Bornman; Menashe Bar-Eli; Ju-Seog Lee; Zahid H Siddik; Gabriel Lopez-Berestein; Anil K Sood
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

9.  Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer.

Authors:  Bradley R Corr; Jessica Finlay-Schultz; Rachel B Rosen; Lubna Qamar; Miriam D Post; Kian Behbakht; Monique A Spillman; Carol A Sartorius
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

10.  Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.

Authors:  Navneet Sangha; Rong Wu; Rork Kuick; Scott Powers; David Mu; Diane Fiander; Kit Yuen; Hidetaka Katabuchi; Hironori Tashiro; Eric R Fearon; Kathleen R Cho
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.